Evidence map›Paper›PMID 35005471›Full record

ArticleIJU case reports2022

A case of miliary tuberculosis following transurethral surgery and prostate biopsy after intravesical Bacillus Calmette-Guerin immunotherapy.

Yoshiaki Kurokawa, Taketo Kawai, Jimpei Miyakawa, Naohiro Makise, Yoshiyuki Akiyama, Yuta Yamada, Yusuke Sato, Daisuke Yamada, Tetsuo Ushiku, Haruki Kume

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in IJU case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yoshiaki KurokawaDepartments of Urology Graduate School of Medicine The University of Tokyo Tokyo Japan.
Taketo KawaiDepartments of Urology Graduate School of Medicine The University of Tokyo Tokyo Japan.ORCID https://orcid.org/0000-0002-7279-2874
Jimpei MiyakawaDepartments of Urology Graduate School of Medicine The University of Tokyo Tokyo Japan.
Naohiro MakiseDepartment of Pathology Graduate School of Medicine The University of Tokyo Tokyo Japan.
Yoshiyuki AkiyamaDepartments of Urology Graduate School of Medicine The University of Tokyo Tokyo Japan.
Yuta YamadaDepartments of Urology Graduate School of Medicine The University of Tokyo Tokyo Japan.
Yusuke SatoDepartments of Urology Graduate School of Medicine The University of Tokyo Tokyo Japan.
Daisuke YamadaDepartments of Urology Graduate School of Medicine The University of Tokyo Tokyo Japan.
Tetsuo UshikuDepartment of Pathology Graduate School of Medicine The University of Tokyo Tokyo Japan.
Haruki KumeDepartments of Urology Graduate School of Medicine The University of Tokyo Tokyo Japan.ORCID https://orcid.org/0000-0001-9841-0857
University of Tokyo Hospital · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIntravesical Bacillus Calmette-Guerin immunotherapy is known to prevent recurrence of bladder cancer, but it can cause tuberculosis infections as an adverse event. CASE PRESENTATION: A 75-year-old man visited our hospital due to hematuria. The patient was diagnosed with bladder cancer and underwent transurethral resection of the bladder tumor. Postoperatively, the patient received Bacillus Calmette-Guerin immunotherapy. One year later, we performed transurethral surgery and prostate biopsy because of cystoscopic findings showing nodulous lesions in the bladder and an elevated serum prostate-specific antigen level. The patient presented with high fever and malaise since the surgery. After careful examination, the patient was diagnosed with miliary tuberculosis caused by

conclusionThe surgery exacerbated the local infection into a systemic infection. The risk of developing miliary tuberculosis should be considered at transurethral surgery or prostate biopsy in patients after intravesical Bacillus Calmette-Guerin immunotherapy.

Indexed as

BCG immunotherapybladder cancermiliary tuberculosisMycobacterium bovissystemic infection

Identifiers

PMID35005471
PMCPMC8720731
OpenAlexW3203379766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.